These three incretin peptides dominate weight-loss research, but they are not equal
Terms to know GLP-1 RA (Glucagon-like peptide-1 receptor agonists): These therapies mimic the bodys natural GLP-1 hormone to regulate blood sugar and promote feelings of fullness
Possible side effects include: Nausea, diarrhea, vomiting, constipation, mild to moderate abdominal pain, headache, fatigue, dyspepsia, dizziness, abdominal distension, belching, hypoglycemia, flatulence, gastroenteritis, loss of lean muscle mass and gastroesophageal reflux disease
By activating three receptors, it helps control blood sugar and supports weight loss by: Boosting insulin release and sensitivity Reducing glucagon to prevent excess glucose production Slowing down digestion (gastric emptying) and making you feel fuller (increased satiety levels), which helps you eat less (reduced calorie intake) Eli Lilly finished their phase II trials for retatrutide and shared the results in June 2023
Monthly Medication Costs (after first-month discount) Compounded semaglutide (injection) $197 3-month plan: $185/mo 6-month plan: $175/mo Compounded semaglutide (microdose) $227 Requires a provider consultation
Genetic factors are also implicated in the development of hypertension